Btk expression is controlled by Oct and BOB.1/OBF.1

Nucleic Acids Research

Volumn 34, Issue 6, 2006, Pages 1807-1815

  Brunner, Cornelia ^a   Wirth, Thomas ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; BRUTON TYROSINE KINASE; DNA; OCTAMER TRANSCRIPTION FACTOR 1; OCTAMER TRANSCRIPTION FACTOR 2; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BOB 1; TRANSCRIPTION FACTOR OBF 1; TRANSCRIPTION FACTOR PU 1; UNCLASSIFIED DRUG; AGAMMAGLOBULINAEMIA TYROSINE KINASE; ONCOPROTEIN; POU2AF1 PROTEIN, MOUSE; PROTO ONCOGENE PROTEIN SPI 1; PROTO-ONCOGENE PROTEIN SPI-1; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; COMPLEX FORMATION; CONTROLLED STUDY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA INTERACTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; ANIMAL; B LYMPHOCYTE; BIOSYNTHESIS; C57BL MOUSE; CELL LINE; DNA RESPONSIVE ELEMENT; GENETICS; METABOLISM; MOLECULAR GENETICS; MOUSE MUTANT; NUCLEOTIDE SEQUENCE;

ANIMALIA; MURINAE;

ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; CELL LINE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; OCTAMER TRANSCRIPTION FACTOR-1; OCTAMER TRANSCRIPTION FACTOR-2; PROMOTER REGIONS (GENETICS); PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RESPONSE ELEMENTS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS;

EID: 33645803177     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkl131     Document Type: Article

References (64)

1. Gunderson,S.I., Murphy,J.T., Knuth,M.W., Steinberg,T.H., Dahlberg,J.H. and Burgess,R.R. (1988) Binding of transcription factors to the promoter of the human U1 RNA gene studied by footprinting. J. Biol. Chem., 263, 17603-17610.
2. Murphy,J.T., Skuzeski,J.T., Lund,E., Steinberg,T.H., Burgess,R.R. and Dahlberg,J.E. (1987) Functional elements of the human U1 RNA promoter. Identification of five separate regions required for efficient transcription and template competition. J. Biol. Chem., 262, 1795-1803.
3. Sive,H.L., Heintz,N. and Roeder,R.G. (1986) Multiple sequence elements are required for maximal in vitro transcription of a human histone H2B gene. Mol. Cell Biol., 6, 3329-3340.
4. Falkner,F.G. and Zachau,H.G. (1984) Correct transcription of an immunoglobulin kappa gene requires an upstream fragment containing conserved sequence elements. Nature, 310, 71-74.
5. Parslow,T.G., Blair,D.L., Murphy,W.J. and Granner,D.K. (1984) Structure of the 5′ ends of immunoglobulin genes: A novel conserved sequence. Proc. Natl Acad. Sci. USA, 81, 2650-2654.
6. Hermanson,G.G., Briskin,M., Sigman,D. and Wall,R. (1989) Immunoglobulin enhancer and promoter motifs 5′ of the B29 B-cell-specific gene. Proc. Natl Acad. Sci. USA, 86, 7341-7345.
7. Thevenin,C., Lucas,B.P., Kozlow,E.J. and Kehrl,J.H. (1993) Cell-type-and stage-specific expression of the CD20/B1 antigen correlates with the activity of a diverged octamer DNA motif present in its promoter. J. Biol. Chem., 268, 5949-5956.
8. Christensen,S.M., Martin,B.K., Tan,S.S. and Weis,J.H. (1992) Identification of sites for distinct DNA binding proteins including Oct-1 and Oct-2 in the Cr2 gene. J. Immunol., 148, 3610-3617.
9. Wirth,T., Staudt,L. and Baltimore,D. (1987) An octamer oligonucleotide upstream of a TATA motif is sufficient for lymphoid-specific promoter activity. Nature, 329, 174-178.
10. Staudt,L.M., Singh,H., Sen,R., Wirth,T., Sharp,P.A. and Baltimore,D. (1986) A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes. Nature, 323, 640-643.
11. Gstaiger,M., Georgiev,O., van Leeuwen,H., van der Vliet,P. and Schaffner,W. (1996) The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with the Oct-1/Oct-2 factors, leading to differential promoter activation. EMBO J., 15, 2781-2790.
12. Luo,Y. and Roeder,R.G. (1995) Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B. Mol. Cell. Biol., 15, 4115-4124.
13. Gstaiger,M., Knoepfel,L., Georgiev,O., Schaffner,W. and Hovens,C.M. (1995) A B-cell coactivator of octamer-binding transcription factors. Nature, 373, 360-362.
14. Strubin,M., Newell,J.W. and Matthias,P. (1995) OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer proteins. Cell, 80, 497-506.
15. Pfisterer,P., Zwilling,S., Hess,J. and Wirth,T. (1995) Functional characterization of the murine homolog of the B-cell-specific coactivator BOB.1/OBF.1. J. Biol. Chem., 270, 29870-29880.
16. Schubart,D.B., Sauter,P., Massa,S., Friedl,E.M., Schwarzenbach,H. and Matthias,P. (1996) Gene structure and characterization of the murine homologue of the B cell-specific transcriptional coactivator OBF-1. Nucleic Acids Res., 24, 1913-1920.
17. Cepek,K.L., Chasman,D.I. and Sharp,P.A. (1996) Sequence-specific DNA binding of the B-cell-specific coactivator OCA-B. Genes Dev., 10, 2079-2088.
18. Babb,R., Cleary,M.A. and Herr,W. (1997) OCA-B is a functional analog of VP16 but targets a separate surface of the Oct-1 POU domain. Mol. Cell. Biol., 17, 7295-7305.
19. Chasman,D., Cepek,K., Sharp,P.A. and Pabo,C.O. (1999) Crystal structure of an OCA-B peptide bound to an Oct-1 POU domain/octamer DNA complex: specific recognition of a protein-DNA interface. Genes Dev., 13, 2650-2657.
20. Yu,X., Wang,L., Luo,Y. and Roeder,R.G. (2001) Identification and characterization of a novel OCA-B isoform. implications for a role in B cell signaling pathways. Immunity, 14, 157-167.
21. Hess,J., Nielsen,P.J., Fischer,K.D., Bujard,H. and Wirth,T. (2001) The B lymphocyte-specific coactivator BOB.1/OBF.1 is required at multiple stages of B-cell development. Mol. Cell Biol., 21, 1531-1539.
22. Qin,X.F., Reichlin,A., Luo,Y., Roeder,R.G. and Nussenzweig,M.C. (1998) OCA-B integrates B cell antigen receptor-, CD40L- and IL 4-mediated signals for the germinal center pathway of B cell development. EMBO J., 17, 5066-5075.
23. Greiner,A., Müller,K., Hess,J., Pfeffer,K., Müller-Hermelink,K.H. and Wirth,T. (2000) BOB.1/OBF.1 expression is upregulated in normal germinal center B cells and germinal center derived B cell lymphomas. Am. J. Pathol., 156, 501-507.
24. Schubart,D.B., Rolink,A., Kosco-Vilbois,M.H., Botteri,F. and Matthias,P. (1996) B-cell-specific coactivator OBF-1/OCA-B/Bob1 required for immune response and germinal centre formation. Nature, 383, 538-542.
25. Kim,U., Qin,F.-F., Gong,S., Stevens,S., Luo,Y., Nussenzweig,M. and Roeder,R.G. (1996) The B-cell-specific transcription coactivator OCAB-B/ OBF-1/Bob-1 is essential for normal production of immunoglobulin isotypes. Nature, 383, 542-547.
26. Nielsen,P.J., Georgiev,O., Lorenz,B. and Schaffner,W. (1996) B lymphocytes are impaired in mice lacking the transcriptional co-activator Bob1/OCA-B/OBF1. Eur. J. Immunol., 26, 3214-3218.
27. Samardzic,T., Marinkovic,D., Nielsen,P.J., Nitschke,L. and Wirth,T. (2002) BOB.1/OBF.1 deficiency affects marginal-zone B-cell compartment. Mol. Cell Biol., 22, 8320-8331.
28. Brunner,C., Marinkovic,D., Klein,J., Samardzic,T., Nitschke,L. and Wirth,T. (2003) B cell-specific transgenic expression of Bcl2 rescues early B lymphopoiesis but not B cell responses in BOB.1/OBF.1-deficient mice. J. Exp. Med., 197, 1205-1211.
29. Zwilling,S., Dieckmann,A., Pfisterer,P., Angel,P. and Wirth,T. (1997) Inducible expression and phosphorylation of coactivator BOB.1/OBF.1 in T cells. Science, 277, 221-225.
30. Sauter,P. and Matthias,P. (1997) The B cell-specific coactivator OBF-1 (OCA-B, Bob-1) is inducible in T cells and its expression is dispensable for IL-2 gene induction. Immunobiology, 198, 207-216.
31. Rosen,F.S., Cooper,M.D. and Wedgwood,R.J. (1984) The primary immunodeficiencies (1). N. Engl. J. Med., 311, 235-242.
32. Brunner,C., Muller,B. and Wirth,T. (2005) Bruton's tyrosine kinase is involved in innate and adaptive immunity. Histol. Histopathol., 20, 945-955.
33. Khan,W.N., Alt,F.W., Gerstein,R.M., Malynn,B.A., Larsson,I., Rathbun,G., Davidson,L., Müller,S., Kantor,A.B., Herzenberg,L.A. et al. (1995) Defective B cell development and function in Btk-deficient mice. Immunity, 3, 283-299.
34. Hendriks,R.W., de Bruijn,M.F., Maas,A., Dingjan,G.M., Karis,A. and Grosveld,F. (1996) Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage. Embo J., 15, 4862-4872.
35. Middendorp,S., Dingjan,G.M. and Hendriks,R.W. (2002) Impaired precursor B cell differentiation in Bruton's tyrosine kinase-deficient mice. J. Immunol., 168, 2695-2703.
36. Fluckiger,A.C., Li,Z., Kato,R.M., Wahl,M.I., Ochs,H.D., Longnecker,R., Kinet,J.P., Witte,O.N., Scharenberg,A.M. and Rawlings,D.J. (1998) Btk/ Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation. Embo J., 17, 1973-1985.
37. Petro,J.B., Rahman,S.M., Ballard,D.W. and Khan,W.N. (2000) Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement. J. Exp. Med., 191, 1745-1754.
38. Bajpai,U.D., Zhang,K., Teutsch,M., Sen,R. and Wortis,H.H. (2000) Bruton's tyrosine kinase links the B cell receptor to nuclear factor kappaB activation. J. Exp. Med., 191, 1735-1744.
39. Schubart,D.B., Rolink,A., Schubart,K. and Matthias,P. (2000) Cutting edge: Lack of peripheral B cells and severe agammaglobulinemia in mice simultaneously lacking Bruton's tyrosine kinase and the B cell-specific transcriptional coactivator OBF-1. J. Immunol., 164, 18-22.
40. Vetrie,D., Vorechovsky,I., Sideras,P., Holland,J., Davies,A., Flinter,F., Hammarstrom,L., Kinnon,C., Levinsky,R., Bobrow,M. et al. (1993) The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature, 361, 226-233.
41. Tsukada,S., Saffran,D.C., Rawlings,D.J., Parolini,O., Allen,R.C., Klisak,I., Sparkes,R.S., Kubagawa,H., Mohandas,T., Quan,S. et al. (1993) Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell, 72, 279-290.
42. Thomas,J.D., Sideras,P., Smith,C.I., Vorechovsky,I., Chapman,V. and Paul,W.E. (1993) Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science, 261, 355-358.
43. Rawlings,D.J., Saffran,D.C., Tsukada,S., Largaespada,D.A., Grimaldi,J.C., Cohen,L., Mohr,R.N., Bazan,J.F., Howard,M., Copeland,N.G. et al. (1993) Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science, 261, 358-361.
44. Sideras,P., Muller,S., Shiels,H., Jin,H., Khan,W.N., Nilsson,L., Parkinson,E., Thomas,J.D., Branden,L., Larsson,I. et al. (1994) Genomic organization of mouse and human Bruton's agammaglobulinemia tyrosine kinase (Btk) loci. J. Immunol., 153, 5607-5617.
45. Oeltjen,J.C., Malley,T.M., Muzny,D.M., Miller,W., Gibbs,R.A. and Belmont,J.W. (1997) Large-scale comparative sequence analysis of the human and murine Bruton's tyrosine kinase loci reveals conserved regulatory domains. Genome Res., 7, 315-329.
46. Himmelmann,A., Thevenin,C., Harrison,K. and Kehrl,J.H. (1996) Analysis of the Bruton's tyrosine kinase gene promoter reveals critical PU.1 and SP1 sites. Blood, 87, 1036-1044.
47. Rohrer,J. and Conley,M.E. (1998) Transcriptional regulatory elements within the first intron of Bruton's tyrosine kinase. Blood, 91, 214-221.
48. Muller,S., Sideras,P., Smith,C.I. and Xanthopoulos,K.G. (1996) Cell specific expression of human Bruton's agammaglobulinemia tyrosine kinase gene (Btk) is regulated by Sp1- and Spi-1/PU.1-family members. Oncogene, 13, 1955-1964.
49. Muller,S., Maas,A., Islam,T.C., Sideras,P., Suske,G., Philipsen,S., Xanthopoulos,K.G., Hendriks,R.W. and Smith,C.I. (1999) Synergistic activation of the human Btk promoter by transcription factors Sp1/3 and PU.1. Biochem. Biophys. Res. Commun., 259, 364-369.
50. Annweiler,A., Müller-Immerglück,M. and Wirth,T. (1992) Oct2 transactivation from a remote enhancer position requires a B-cell-restricted activity. Mol. Cell. Biol., 12, 3107-3116.
51. Kistler,B., Pfisterer,P. and Wirth,T. (1995) Lymphoid- and myeloid-specific activity is determined by the combinatorial action of octamer and ETS transcription factors. Oncogene, 11, 1095-1106.
52. Laumen,H., Nielsen,P.J. and Wirth,T. (2000) The BOB.1/OBF.1 coactivator is essential for octamer-dependent transcription in B cells. Eur. J. Immunol., 30, 458-469.
53. Lernbecher,T., Müller,U. and Wirth,T. (1993) Distinct NF-kB/Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature, 365, 767-770.
54. Wirth,T. and Baltimore,D. (1988) Nuclear factor NF-kB can interact functionally with its cognate binding site to provide lymphoid-specific promoter function. EMBO J., 7, 3109-3113.
55. Luo,Y., Fujii,H., Gerster,T. and Roeder,R.G. (1992) A novel B cell-derived coactivator potentiates the activation of immunoglobulin promoters by octamer-binding transcription factors. Cell, 71, 231-241.
56. Brunner,C., Laumen,H., Nielsen,P.J., Kraut,N. and Wirth,T. (2003) Expression of the aldehyde dehydrogenase 2-like gene is controlled by BOB.1/OBF.1 in B lymphocytes. J. Biol. Chem., 278, 45231-45239.
57. Wirth,T., Priess,A., Annweiler,A., Zwilling,S. and Oeler,B. (1991) Multiple Oct2 isoforms are generated by alternative splicing. Nucleic Acids Res., 19, 43-51.
58. Pfisterer,P., Annweiler,A., Ullmer,C., Corcoran,L. and Wirth,T. (1994) Differential transactivation potential of Oct1 and Oct2 is determined by additional B cell-specific activities. EMBO J., 13, 1654-1663.
59. Hess,J., Nielsen,P.J., Fischer,K.D., Bujard,H. and Wirth,T. (2001) The B lymphocyte-specific coactivator BOB.1/OBF.1 is required at multiple stages of B-cell development. Mol. Cell Biol., 21, 1531-1539.
60. Matthias,P. and Rolink,A.G. (2005) Transcriptional networks in developing and mature B cells. Nat. Rev. Immunol., 5, 497-508.
61. Botquin,V., Hess,H., Fuhrmann,G., Anastassiadis,C., Gross,M.K., Vriend,G. and Scholer,H.R. (1998) New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2. Genes Dev., 12, 2073-2090.
62. Lins,K., Remenyi,A., Tomilin,A., Massa,S., Wilmanns,M., Matthias,P. and Scholer,H.R. (2003) OBF1 enhances transcriptional potential of Oct1. Embo J., 22, 2188-2198.
63. Tomilin,A., Remenyi,A., Lins,K., Bak,H., Leidel,S., Vriend,G., Wilmanns,M. and Scholer,H.R. (2000) Synergism with the coactivator OBF-1 (OCA-B, BOB-1) is mediated by a specific POU dimer configuration. Cell, 103, 853-864.
64. Kerner,J.D., Appleby,M.W., Mohr,R.N., Chien,S., Rawlings,D.J., Maliszewski,C.R., Witte,O.N. and Perlmutter,R.M. (1995) Impaired expansion of mouse B cell progenitors lacking Btk. Immunity, 3, 301-312.